BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32827272)

  • 1. Non-Pharmacologic Management of Splenomegaly for Patients with Myelofibrosis: Is There Any Role for Splenectomy or Splenic Radiation in 2020?
    Sankar K; Pettit K
    Curr Hematol Malig Rep; 2020 Oct; 15(5):391-400. PubMed ID: 32827272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modern management of splenomegaly in patients with myelofibrosis.
    Tremblay D; Schwartz M; Bakst R; Patel R; Schiano T; Kremyanskaya M; Hoffman R; Mascarenhas J
    Ann Hematol; 2020 Jul; 99(7):1441-1451. PubMed ID: 32417942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative splenectomy in myelofibrosis with myeloid metaplasia.
    Mesa RA; Tefferi A
    Leuk Lymphoma; 2001; 42(5):901-11. PubMed ID: 11697645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenic irradiation as a component of a reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in myelofibrosis with massive splenomegaly.
    Ito T; Akagi K; Kondo T; Kawabata H; Ichinohe T; Takaori-Kondo A
    Tohoku J Exp Med; 2012 Dec; 228(4):295-9. PubMed ID: 23117264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenic irradiation in myelofibrosis with myeloid metaplasia: a review.
    Elliott MA; Tefferi A
    Blood Rev; 1999 Sep; 13(3):163-70. PubMed ID: 10527268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of splenectomy in the treatment of myelofibrosis].
    Melikian AL; Kolosova LIu; Sokolova MA; Kovrigina AM; Silaev MA; Giliazitdinova EA; Gemdzhian ÉG; Karagiulian SR
    Ter Arkh; 2013; 85(8):69-76. PubMed ID: 24137967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopically assisted splenectomy following preoperative splenic artery embolization using contour emboli for myelofibrosis with massive splenomegaly.
    Iwase K; Higaki J; Mikata S; Tanaka Y; Yoshikawa M; Hori S; Osuga K; Kosugi S; Tamaki T; Kamiike W
    Surg Laparosc Endosc Percutan Tech; 1999 Jun; 9(3):197-202. PubMed ID: 10804000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy for splenomegaly.
    Mod H; Prasiko G; Jha AK; Chaurasia PP; Srivastava R
    JNMA J Nepal Med Assoc; 2005; 44(159):97-9. PubMed ID: 16554863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How I treat symptomatic splenomegaly in patients with myelofibrosis.
    Mesa RA
    Blood; 2009 May; 113(22):5394-400. PubMed ID: 19332765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The choice between splenectomy and medical treatment in patients with advanced agnogenic myeloid metaplasia.
    Benbassat J; Gilon D; Penchas S
    Am J Hematol; 1990 Feb; 33(2):128-35. PubMed ID: 1689100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliative irradiation of the spleen.
    McFarland JT; Kuzma C; Millard FE; Johnstone PA
    Am J Clin Oncol; 2003 Apr; 26(2):178-83. PubMed ID: 12714892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive splenic radiotherapy for symptomatic splenomegaly management in myeloproliferative disorders.
    Sager O; Beyzadeoglu M; Dincoglan F; Demiral S; Uysal B; Gamsiz H; Akin M; Gundem E; Dirican B
    Tumori; 2015; 101(1):84-90. PubMed ID: 25702680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia.
    Elliott MA; Chen MG; Silverstein MN; Tefferi A
    Br J Haematol; 1998 Nov; 103(2):505-11. PubMed ID: 9827926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenectomy in Myelofibrosis: Indications, Efficacy, and Complications.
    Malato A; Rossi E; Tiribelli M; Mendicino F; Pugliese N
    Clin Lymphoma Myeloma Leuk; 2020 Sep; 20(9):588-595. PubMed ID: 32482540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical and radiotherapeutic approaches for myelofibrosis with myeloid metaplasia.
    Mesa RA; Tefferi A
    Semin Oncol; 2005 Aug; 32(4):403-13. PubMed ID: 16202686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenectomy for massive splenomegaly.
    Sharp P; Grace CS; Rozenberg MC; Ham JM
    Aust N Z J Surg; 1985 Oct; 55(5):489-92. PubMed ID: 3868413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splenic irradiation as palliative treatment for symptomatic splenomegaly due to secondary myelofibrosis: a multi-institutional experience.
    Pistevou-Gombaki K; Zygogianni A; Kantzou I; Kyrgias G; Mystakidou K; Kouvaris J; Klonizakis I; Tsirigotis P; Pappa V; Siakantari M; Eleftheriadis N; Georgakopoulos J; Sarris G; Kelekis N; Kouloulias V
    J BUON; 2015; 20(4):1132-6. PubMed ID: 26416067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Myelofibrosis: A Moving Target.
    Cerquozzi S; Farhadfar N; Tefferi A
    Cancer J; 2016; 22(1):51-61. PubMed ID: 26841017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenectomy for massive splenomegaly due to myeloid metaplasia.
    Morgenstern L
    Am J Surg; 1971 Aug; 122(2):288-93. PubMed ID: 5561345
    [No Abstract]   [Full Text] [Related]  

  • 20. Risks and benefits of splenectomy in myelofibrosis with myeloid metaplasia: a retrospective analysis of 26 cases.
    Akpek G; McAneny D; Weintraub L
    J Surg Oncol; 2001 May; 77(1):42-8. PubMed ID: 11344482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.